Belpointe Asset Management LLC Emergent Bio Solutions Inc. Transaction History

Belpointe Asset Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$7.79 - $16.29 $584 - $1,221	-75 Reduced 15.21%	418 $4,000
Q4 2022 Feb 08, 2023	BUY	$11.0 - $21.45 $5,423 - $10,574	493 New	493 $5,000
Q4 2021 Feb 15, 2022	SELL	$33.11 - $55.01 $113,004 - $187,749	-3,413 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$50.07 - $66.05 $65,441 - $86,327	1,307 Added 62.06%	3,413 $161,000
Q2 2021 Aug 09, 2021	BUY	$56.61 - $80.46 $119,220 - $169,448	2,106 New	2,106 $122,000

160

33.8M

453K

931K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $420M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of Belpointe Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Belpointe Asset Management LLC with notifications on news.